MedPath

DEFITELIO

DEFITELIO

Approved
DIN Number

02465981

Drug Class

Human

Market Date

Sep 6, 2017

Company
HC

JAZZ PHARMACEUTICALS IRELAND LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02465981
AIG Number0159250001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
B01AX01 DEFIBROTIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification20:12.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

DEFIBROTIDEActive
Strength: 80 MG / ML
Monograph: DEFIBROTIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.